The Safety and Tolerability of Ferric Citrate as a Phosphate Binder in Dialysis Patients

Publisher： Karger

E-ISSN： 1660-2110|121|1-2|c25-c29

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.121, Iss.1-2, 2012-10, pp. : c25-c29

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A long-term, open-label extension study on the safety of treatment with lanthanum carbonate, a new phosphate binder, in patients receiving hemodialysis

By Finn William F.   Joy Melanie S.    

Current Medical Research and Opinion, Vol. 21, Iss. 5, 2005-05 ,pp. : 657-664

Informa Healthcare

Access to resources Recommend Favorite

Colestipol as a phosphate binder

By  

NEPHROLOGY, Vol. 20, Iss. 4, 2015-04 ,pp. : 250-256

John Wiley & Sons Inc

Access to resources Recommend Favorite

Choosing Not to Take Phosphate Binders: The Role of Dialysis Patients’ Medication Beliefs

By  

Nephron Clin Pract, Vol. 119, Iss. 3, 2011-08 ,pp. : c205-c213

Karger

Access to resources Recommend Favorite

Safety and tolerability of prolonged-release nicotinic acid in statin-treated patients

By Birjmohun R. S.   Kastelein J. J. P.   Poldermans D.   Stroes E. S. G   Hostalek U.   Assmann G.  

Current Medical Research and Opinion, Vol. 23, Iss. 7, 2007-07 ,pp. : 1707-1713

Informa Healthcare

Access to resources Recommend Favorite

Clindamycin phosphate 1·2%–benzoyl peroxide 3·0% fixed‐dose combination gel has an effective and acceptable safety and tolerability profile for the treatment of acne vulgaris in Japanese patients: a phase III, multicentre, randomised, single‐blinded, active‐controlled, parallel‐group study

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 172, Iss. 2, 2015-02 ,pp. : 494-503

John Wiley & Sons Inc

Access to resources Recommend Favorite